Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome.
about
Adipokines, metabolic syndrome and rheumatic diseasesLipocalin-2 induces cardiomyocyte apoptosis by increasing intracellular iron accumulation.The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases.Direct effects of adipokines on the heart: focus on adiponectin.Lipocalin-2 (NGAL) Attenuates Autophagy to Exacerbate Cardiac Apoptosis Induced by Myocardial Ischemia.Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels.Lipocalin-2 induces NLRP3 inflammasome activation via HMGB1 induced TLR4 signaling in heart tissue of mice under pressure overload challenge.Adipose-derived lipocalin 14 alleviates hyperglycaemia by suppressing both adipocyte glycerol efflux and hepatic gluconeogenesis in mice.Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation.Adipocytokine levels in women with anorexia nervosa. Relationship with weight restoration and disease duration.Biomechanics, obesity, and osteoarthritis. The role of adipokines: When the levee breaks.Susceptibility of adult and senescent Brown Norway rats to repeated ozone exposure: an assessment of behavior, serum biochemistry and cardiopulmonary function.
P2860
Q26865268-33E47986-25A1-401A-9948-95EF7FA82EC7Q35763055-5ABAB7E6-A761-44AA-9EC9-FF53D5124F9EQ36762507-D98AE727-3986-4F3E-95D2-842726EAC83EQ38034678-ED404378-47D7-41D5-AC91-C00E4586C6D9Q38734613-AD73BB5C-FB2F-485F-8CEA-1C090EC891FCQ40680047-049E112F-05C0-4340-A358-633AE16397A0Q41009164-1DE490D9-F95C-4FC1-AEF1-5D6968D6CDF9Q41107429-9ED80EF7-1217-4D72-83BE-2F4CA5353D65Q47204696-626208F1-7227-4AA9-94F6-0A92FA85B5D2Q47221170-6B06F921-27BF-4A47-91B8-3B2D026BCD50Q50100973-B0525396-EB75-40C7-9110-F89A82CFC246Q53340449-FABFC057-5B84-4C93-96E2-E5FD8299251B
P2860
Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Emerging clinical and experime ...... calin-2 in metabolic syndrome.
@ast
Emerging clinical and experime ...... calin-2 in metabolic syndrome.
@en
type
label
Emerging clinical and experime ...... calin-2 in metabolic syndrome.
@ast
Emerging clinical and experime ...... calin-2 in metabolic syndrome.
@en
prefLabel
Emerging clinical and experime ...... calin-2 in metabolic syndrome.
@ast
Emerging clinical and experime ...... calin-2 in metabolic syndrome.
@en
P2860
P1476
Emerging clinical and experime ...... ocalin-2 in metabolic syndrome
@en
P2093
Gary Sweeney
Jong Ho Lee
P2860
P304
P356
10.1111/J.1440-1681.2011.05557.X
P577
2012-02-01T00:00:00Z